Paper7238564
Human pharmacokinetics of tolfenamic acid, a new anti-inflammatory agent.
Pentikäinen PJ and 2 others. Eur J Clin Pharmacol, 1981. Cited by 60 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Human pharmacokinetics of tolfenamic acid, a new anti-inflammatory agent. Papers, record 7238564. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7238564
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Inflammatory Agents | Major topic |
| ortho-Aminobenzoates | Major topic |
| Administration, Oral | |
| Adult | |
| Biological Availability | |
| Female | |
| Glucuronates | |
| Humans | |
| Infusions, Parenteral | |
| Intestinal Absorption | |
| Kinetics | |
| Models, Biological | |
| Protein Binding |
Source PubMed
References15
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 579,121 | [On biochemistry and pharmacokinetics of etofenamate/studies in man (author's transl)]. | Arzneimittelforschung | 1977 | https://conductscience.org/library/papers/579121 | PubMed |
| 2 | 1,086,507 | Prolonged treatment with tolfenamic acid in inflammatory rheumatic diseases. | Scand J Rheumatol | 1976 | https://conductscience.org/library/papers/1086507 | PubMed |
| 3 | 5,652,110 | Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment. | J Pharm Sci | 1968 | https://conductscience.org/library/papers/5652110 | PubMed |
| 4 | 432,132 | [Mefenamic acid pharmacokinetics in patients with congestive heart failure]. | Pol Tyg Lek | 1979 | https://conductscience.org/library/papers/432132 | PubMed |
| 5 | 373,084 | A comparative, double-blind study on tolfenamic acid in the treatment of rheumatoid arthritis. | Scand J Rheumatol Suppl | 1979 | https://conductscience.org/library/papers/373084 | PubMed |
| 6 | 527,637 | The pharmacokinetics of diclofenac sodium following intravenous and oral administration. | Eur J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/527637 | PubMed |
| 7 | 387,372 | Naproxen up to date: a review of its pharmacological properties and therapeutic efficacy and use in rheumatic diseases and pain states. | Drugs | 1979 | https://conductscience.org/library/papers/387372 | PubMed |
| 8 | 824,724 | Inhibition of prostaglandin biosynthesis by tolfenamic acid in vitro. | Scand J Rheumatol | 1976 | https://conductscience.org/library/papers/824724 | PubMed |
| 9 | 5,671,338 | New method for calculating the intrinsic absorption rate of drugs. | J Pharm Sci | 1968 | https://conductscience.org/library/papers/5671338 | PubMed |
| 10 | 5,151,301 | Age differences in drug binding by plasma proteins: studies on human foetuses, neonates and adults. | Eur J Clin Pharmacol | 1971 | https://conductscience.org/library/papers/5151301 | PubMed |
| 11 | 89,390 | Tolfenamic acid is as effective as ergotamine during migraine attacks. | Lancet | 1979 | https://conductscience.org/library/papers/89390 | PubMed |
| 12 | 707,953 | [Pharmacokinetic profil of ketoprofen (author's transl)]. | Ann Pharm Fr | 1978 | https://conductscience.org/library/papers/707953 | PubMed |
| 13 | 4,979,052 | Experimental observations on flufenamic, mefenamic and meclofenamic acids. 3. Metabolic disposition. | Ann Phys Med | 1966 | https://conductscience.org/library/papers/4979052 | PubMed |
| 14 | 324,748 | Fenoprofen: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases. | Drugs | 1977 | https://conductscience.org/library/papers/324748 | PubMed |
| 15 | 5,411,325 | Assessment of pharmacokinetic constants from postinfusion blood curves obtained after I.V. infusion. | J Pharm Sci | 1970 | https://conductscience.org/library/papers/5411325 | PubMed |
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 60 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,362,921 | Antagonistic drug interactions protect commensal Bacteroidaceae from macrolides via an RND-type efflux pump. | Gut Microbes | 2025 | https://conductscience.org/library/papers/41362921 | PubMed |
| 38,952,278 | Pharmacokinetics, bioavailability and plasma protein binding of tolfenamic acid in rainbow trout (Oncorhynchus mykiss). | Vet Med Sci | 2024 | https://conductscience.org/library/papers/38952278 | PubMed |
| 37,440,786 | Copper-catalyzed N-arylation of amines with aryliodonium ylides in water. | Beilstein J Org Chem | 2023 | https://conductscience.org/library/papers/37440786 | PubMed |
| 37,291,774 | Analysis of Tolfenamic Acid using a Simple, Rapid, and Stability-indicating Validated HPLC Method. | Antiinflamm Antiallergy Agents Med Chem | 2024 | https://conductscience.org/library/papers/37291774 | PubMed |
| 36,834,716 | Enhanced NSAIDs Solubility in Drug-Drug Formulations with Ciprofloxacin. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36834716 | PubMed |
| 36,350,125 | Antimicrobial Activity of Auranofin, Cannabidivarin, and Tolfenamic Acid against Multidrug-Resistant Neisseria gonorrhoeae. | Microbiol Spectr | 2022 | https://conductscience.org/library/papers/36350125 | PubMed |
| 35,215,645 | Polyelectrolyte Multilayer Films as a Potential Buccal Platform for Drug Delivery. | Polymers (Basel) | 2022 | https://conductscience.org/library/papers/35215645 | PubMed |
| 32,393,483 | Repurposing Fenamic Acid Drugs To Combat Multidrug-Resistant Neisseria gonorrhoeae. | Antimicrob Agents Chemother | 2020 | https://conductscience.org/library/papers/32393483 | PubMed |
| 30,737,267 | Identification of Novel Inhibitors of Auxin-Induced Ca2+ Signaling via a Plant-Based Chemical Screen. | Plant Physiol | 2019 | https://conductscience.org/library/papers/30737267 | PubMed |
| 24,073,394 | Development and characterization of novel polyurethane films impregnated with tolfenamic acid for therapeutic applications. | Biomed Res Int | 2013 | https://conductscience.org/library/papers/24073394 | PubMed |
| 17,618,427 | Tolfenamic acid is a potent CYP1A2 inhibitor in vitro but does not interact in vivo: correction for protein binding is needed for data interpretation. | Eur J Clin Pharmacol | 2007 | https://conductscience.org/library/papers/17618427 | PubMed |
| 8,983,935 | Pharmacokinetics of tolfenamic acid in pediatric patients after single oral dose. | Eur J Drug Metab Pharmacokinet | 1995 | https://conductscience.org/library/papers/8983935 | PubMed |
| 7,708,126 | Effects of non-steroidal anti-inflammatory drugs on polymorphonuclear leukocyte functions in vitro: focus on fenamates. | Naunyn Schmiedebergs Arch Pharmacol | 1994 | https://conductscience.org/library/papers/7708126 | PubMed |
| 7,166,179 | Human metabolism of tolfenamic acid. II. Structure of metabolites and C-13 NMR assignments of fenamates. | Eur J Drug Metab Pharmacokinet | 1982 | https://conductscience.org/library/papers/7166179 | PubMed |
| 7,166,178 | Human metabolism of tolfenamic acid. I. Isolation, preliminary characterization and pharmacokinetics of tolfenamic acid and its metabolites. | Eur J Drug Metab Pharmacokinet | 1982 | https://conductscience.org/library/papers/7166178 | PubMed |
| 6,691,890 | Effects of migraine attack and metoclopramide on the absorption of tolfenamic acid. | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6691890 | PubMed |
| 6,508,975 | Do gastric contents modify antidotal efficacy of oral activated charcoal? | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6508975 | PubMed |
| 6,352,138 | Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs. | Clin Pharmacokinet | 1983 | https://conductscience.org/library/papers/6352138 | PubMed |
| 6,334,608 | Pharmacokinetics of tolfenamic acid: disposition in bile, blood and urine after intravenous administration to man. | Eur J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6334608 | PubMed |
| 3,876,221 | Pharmacokinetics of tolfenamic acid in patients with cirrhosis of the liver. | Eur J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/3876221 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7238564
GET https://conductscience.org/api/papers/v1/7238564/cited_by?page=2